Study of a new drug for advanced urological and other solid tumors
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests a new drug (SI-B036) for people with advanced urological tumors or other solid tumors that have spread. The goal is to see if the drug is safe and effective, and it might help shrink tumors or slow their growth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You must have advanced cancer (a urological tumor or another type of solid tumor) that has spread, and at least one tumor that can be measured on scans.
- You need to be in good enough health to carry out daily activities (ECOG score 0 or 1).
- You must be able to provide a tumor tissue sample (from a past biopsy within 2 years or a fresh one).
- Any side effects from previous treatments must have mostly gone away (recovered to grade 1 or better).
- You must have adequate heart, kidney, liver, and blood clotting function, and controlled blood pressure and diabetes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug called SI-B036 for people with advanced breast cancer or other solid tumors that have spread. The goal is to see if the drug is safe and to find the best dose.
This trial tests an experimental drug, BA1203, for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if the drug is safe and whether it can help shrink tumors.
This trial tests two new drugs (BL-B01D1 and SI-B003) alone or with a standard immunotherapy for advanced gastrointestinal cancers. The goal is to see if these combinations shrink tumors and are safe.
This trial tests a new drug, SCTB39G, for people with advanced solid tumors that haven't responded to other treatments. The goal is to see if it can shrink tumors and improve survival, and to find the best dose. Participation involves regular treatment and check-ups.
This trial tests a new drug called BL-B01D1, alone or combined with another drug (SI-B003), for people with cervical or other gynecologic cancers that have spread or come back after standard treatments. The goal is to see if this treatment can help when other options have stopped working.
This study tests an experimental medicine called SI-B036 for people with advanced gynecological cancers or other solid tumors that have spread. The goal is to see if the drug is safe and how well it might work.
Hear when a new Urological Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.